JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB134360

PerCP/Cy5.5® Anti-CD90 / Thy1 antibody [5E10]

Be the first to review this product! Submit a review

|

(4 Publications)

Mouse Monoclonal CD90 / Thy1 antibody - conjugated to PerCP/Cy5.5®. Suitable for Flow Cyt and reacts with Human samples. Cited in 4 publications. Immunogen corresponding to Cell preparation containing THY1 protein.

View Alternative Names

CD90, Thy-1 membrane glycoprotein, CDw90, Thy-1 antigen, THY1

1 Images
Flow Cytometry - PerCP/Cy5.5® Anti-CD90 / Thy1 antibody [5E10] (AB134360)
  • Flow Cyt

Unknown

Flow Cytometry - PerCP/Cy5.5® Anti-CD90 / Thy1 antibody [5E10] (AB134360)

Flow cytometry analysis of HEL cell line with Mouse IgG1 kappa Isotype Control PerCP-Cy5.5 (open histogram) or ab134360 at 5 µl (0.25 µg)/test (filled histogram). Total viable cells were used for analysis.

Key facts

Host species

Mouse

Clonality

Monoclonal

Clone number

5E10

Isotype

IgG1

Light chain type

kappa

Conjugation

PerCP/Cy5.5®

Excitation/Emission

Ex: 482nm, Em: 695nm

Carrier free

No

Reacts with

Human

Applications

Flow Cyt

applications

Immunogen

Cell preparation containing THY1 protein. The exact immunogen used to generate this antibody is proprietary information.

P04216

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "FlowCyt" : {"fullname" : "Flow Cytometry", "shortname":"Flow Cyt"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "FlowCyt-species-checked": "testedAndGuaranteed", "FlowCyt-species-dilution-info": "5 µL for 10^6 Cells", "FlowCyt-species-notes": "<p><a href='/en-us/products/primary-antibodies/percp-cy55-mouse-igg1-kappa-monoclonal-mopc-21-isotype-control-ab157226'>ab157226</a> - Mouse monoclonal IgG1, is suitable for use as an isotype control with this antibody.</p>" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein G
Storage buffer
pH: 7.2 Preservative: 0.09% Sodium azide Constituents: PBS, 0.2% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
+4°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

CD90 also known as Thy1 is a glycoprotein with a molecular mass of approximately 25-37 kDa. It is highly conserved across species and found on the surface of various cell types including fibroblasts neurons and endothelial cells. CD90 is expressed in these cells in tissues such as the brain thymus and lungs. Researchers use anti-CD90 antibodies for detection often in combination with CD90 FITC in immunofluorescence assays. CD90 serves as a useful cell marker particularly in identifying mesenchymal stem cells (MSCs).
Biological function summary

CD90 plays a role in cell-cell and cell-matrix interactions contributing to cellular adhesion migration and signal transduction. It functions as part of a complex involving integrins which mediate its interaction with the extracellular matrix. This protein also influences T-cell activation reflecting its importance in immune response regulation. Its presence aids in modulating response to injury and promoting tissue repair due to its association with stem and progenitor cells.

Pathways

CD90 engagement affects focal adhesion and MAPK signaling pathways. It interacts with integrins like αvβ3 and α5β1 influencing cell movement and proliferation processes. CD90 involvement in these pathways allows it to regulate responses important for cell survival and communication within various tissues. These interactions highlight the protein's role in maintaining cellular homeostasis and regulating physiological processes.

CD90 has associations with fibrosis and cancer. In fibrotic conditions CD90 expression affects fibroblast activity influencing tissue scarring in organs such as the liver and lungs. In cancer CD90 modifies tumor progression and metastasis by impacting cell adhesion and migration with connections to proteins like TGF-beta which further drive these processes. Understanding CD90 in disease contexts facilitates the development of therapeutic strategies aimed at modulating its activity.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

May play a role in cell-cell or cell-ligand interactions during synaptogenesis and other events in the brain.
See full target information THY1

Publications (4)

Recent publications for all applications. Explore the full list and refine your search

International journal of molecular sciences 26: PubMed40869109

2025

Exploring the Heterogeneity of Cancer-Associated Fibroblasts via Development of Patient-Derived Cell Culture of Breast Cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Anna Ilyina,Anastasia Leonteva,Ekaterina Berezutskaya,Maria Abdurakhmanova,Mikhail Ermakov,Sergey Mishinov,Elena Kuligina,Sergey Vladimirov,Maria Bogachek,Vladimir Richter,Anna Nushtaeva

International journal of molecular sciences 24: PubMed37240176

2023

Derivation of Human Corneal Keratocytes from ReLEx SMILE Lenticules for Cell Therapy and Tissue Engineering.

Applications

Unspecified application

Species

Unspecified reactive species

Maria A Surovtseva,Irina I Kim,Natalia A Bondarenko,Alexander P Lykov,Kristina Yu Krasner,Elena V Chepeleva,Nataliya P Bgatova,Alexander N Trunov,Valery V Chernykh,Olga V Poveshchenko

International journal of molecular sciences 24: PubMed36768815

2023

"Pulsed Hypoxia" Gradually Reprograms Breast Cancer Fibroblasts into Pro-Tumorigenic Cells via Mesenchymal-Epithelial Transition.

Applications

Unspecified application

Species

Unspecified reactive species

Anna Nushtaeva,Mikhail Ermakov,Maria Abdurakhmanova,Olga Troitskaya,Tatyana Belovezhets,Mikhail Varlamov,Tatyana Gayner,Vladimir Richter,Olga Koval

International journal of molecular medicine 42:2193-2202 PubMed30015833

2018

Regenerative potential of human nucleus pulposus resident stem/progenitor cells declines with ageing and intervertebral disc degeneration.

Applications

Unspecified application

Species

Unspecified reactive species

Hao Wu,Yupan Shang,Jiayue Yu,Xiaoli Zeng,Jinhua Lin,Mei Tu,Lek Hang Cheang,Jiaqing Zhang
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com